Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05377723 · ClinicalTrials.gov registry record · NA

Abdominal Scar Improvement in Microsurgical Breast Reconstruction

A NA study of Breast Reconstruction and Cicatrix, sponsored by Stanford University.

Active
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05377723 is a NA study of Breast Reconstruction and Cicatrix that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 30 participants, below the 392-participant average among 18 other Breast Reconstruction trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05377723, a NA study of Breast Reconstruction and Cicatrix, is active but no longer recruiting, sponsored by Stanford University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

Microsurgical breast reconstruction is most commonly performed with free abdominal flaps, which leave a long transverse lower abdominal scar. Due to tension across the incision, these scars frequently widen and hypertrophy. Hence, modalities that can reduce this tendency, thus, improving scar appearance are desirable. Here, we wish to investigate the impact of the Neodyne embrace device on postoperative abdominal scar appearance. The proposed study is novel in that it is the first RCT investigating the effect of the embrace device on scar appearance in the context of microsurgical breast reconstruction.

Interventions

  • DEVICE Neodyne Device

Study Locations (1)

California

  • Stanford University Medical Center - Stanford

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2022-10-31
Est. Completion 2026-04
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT05377723

The ClinicalTrials.gov registry entry for NCT05377723 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 392-participant average among 18 other Breast Reconstruction trials with a reported enrollment target (92% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Breast Reconstruction appearing as the primary indexed condition, and to 1 intervention - of which Neodyne Device is the first listed.

NCT05377723 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05377723 about?

NCT05377723 is a clinical study titled "Abdominal Scar Improvement in Microsurgical Breast Reconstruction". Microsurgical breast reconstruction is most commonly performed with free abdominal flaps, which leave a long transverse lower abdominal scar. Due to tension across the incision, these scars frequently widen and hypertrophy. Hence, modalities that can reduce this tendency, thus, improving scar appear...

What is the current status of trial NCT05377723?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-10-31. Estimated completion is 2026-04.

What conditions does trial NCT05377723 study?

This clinical trial studies the following conditions: Breast Reconstruction, Cicatrix.

What interventions are being tested in trial NCT05377723?

The interventions under investigation include: Neodyne Device (DEVICE).

Who is sponsoring clinical trial NCT05377723?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05377723 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Reconstruction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.